Atlas Trials

Nodes-sparing Short-course Radiation Combined With CAPOX and Tislelizumab for MSS Middle and Low Rectal Cancer

Clinical trial NCT05972655 · RECRUITING

Trial details

NCT number
NCT05972655
Sponsor
Sir Run Run Shaw Hospital
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Low Rectal Cancer
Start date
2023-08-02
Primary completion
2024-08-20
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.